Wave Life Sciences (WVE) News Today $11.13 -0.20 (-1.77%) Closing price 04:00 PM EasternExtended Trading$11.22 +0.09 (+0.81%) As of 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Wave Life Sciences (NASDAQ:WVE) Stock Crosses Below 50 Day Moving Average - What's Next?Wave Life Sciences (NASDAQ:WVE) Shares Pass Below 50-Day Moving Average - What's Next?February 20 at 7:37 AM | marketbeat.comWhat Makes Wave Life Sciences Ltd. (WVE) an Investment Bet?February 19 at 10:05 AM | insidermonkey.comWave Life Sciences (NASDAQ:WVE) Trading Down 5.8% - Here's WhyWave Life Sciences (NASDAQ:WVE) Trading Down 5.8% - Here's WhyFebruary 10, 2025 | marketbeat.comWave Life Sciences USA, Inc.: Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in ObesityFebruary 6, 2025 | finanznachrichten.deWave Life Sciences begins Phase 1 obesity trialFebruary 6, 2025 | msn.comWave Life Sciences announces CTA approval, initiation of Phase 1 INLIGHTFebruary 6, 2025 | markets.businessinsider.comWave Life Sciences initiates early stage clinical trial of WVE-007 in obesityFebruary 6, 2025 | msn.comWave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in ObesityFebruary 6, 2025 | globenewswire.comWave Life Sciences Ltd. (NASDAQ:WVE) Given Average Recommendation of "Buy" by BrokeragesWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) has been assigned an average rating of "Buy" from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, seven have issued a buy rating and one has assignedFebruary 6, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Down 3.6% - Here's What HappenedWave Life Sciences (NASDAQ:WVE) Trading Down 3.6% - Here's What HappenedFebruary 4, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) shareholders have earned a 69% CAGR over the last three yearsFebruary 4, 2025 | finance.yahoo.comWave Life Sciences Ltd. (NASDAQ:WVE) Stock Holdings Increased by China Universal Asset Management Co. Ltd.China Universal Asset Management Co. Ltd. boosted its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 126.2% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 54,267 shares of the company's stock after purchasFebruary 2, 2025 | marketbeat.comMoody Aldrich Partners LLC Increases Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Moody Aldrich Partners LLC grew its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 31.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 398,475 shares of the company's stock after purchasing an additional 95,January 29, 2025 | marketbeat.comWave Life Sciences: Strategic Initiatives and Promising Milestones Drive Buy RatingJanuary 15, 2025 | markets.businessinsider.comWave Life Sciences: Buy Rating Based on Promising Clinical Updates and RNA Editing AdvancementsJanuary 14, 2025 | markets.businessinsider.comWave Life Sciences announces expected 2025 milestonesJanuary 13, 2025 | markets.businessinsider.comIs Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential?January 13, 2025 | insidermonkey.comWave Life Sciences USA, Inc.: Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan PresentationJanuary 13, 2025 | finanznachrichten.deWave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan PresentationJanuary 13, 2025 | finance.yahoo.comBarclays PLC Has $1.31 Million Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Barclays PLC boosted its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 171.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 159,241 shares of the company's stock after buying an additional 10January 13, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Given Average Recommendation of "Buy" by AnalystsWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) has received an average recommendation of "Buy" from the nine research firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, seven have issued a buy recommendation andJanuary 12, 2025 | marketbeat.comIs Wave Life Sciences Ltd. (WVE) the Best Growth Stock to Buy Now Under $25?January 9, 2025 | insidermonkey.comWave Life Sciences Is A Buy On Pipeline ProspectsJanuary 8, 2025 | seekingalpha.comWave Life Sciences (NASDAQ:WVE) Trading Down 4% - Here's What HappenedWave Life Sciences (NASDAQ:WVE) Trading Down 4% - Should You Sell?January 6, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Stock Price Up 7.7% - What's Next?Wave Life Sciences (NASDAQ:WVE) Trading 7.7% Higher - What's Next?January 2, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Shares Acquired by Geode Capital Management LLCGeode Capital Management LLC lifted its stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 14.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,269,664 shares of the company's stock after purchasing an addDecember 29, 2024 | marketbeat.comBarclays PLC Acquires 100,498 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)Barclays PLC increased its stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 171.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 159,241 shares of the company's stock after buying an addiDecember 29, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Stock Price Down 2.6% - Here's WhyWave Life Sciences (NASDAQ:WVE) Trading Down 2.6% - Should You Sell?December 26, 2024 | marketbeat.comWave Life Sciences’ WVE-007: A Promising New Player in Obesity TreatmentDecember 25, 2024 | markets.businessinsider.comState Street Corp Has $19.03 Million Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)State Street Corp lifted its position in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 2.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,321,248 shares of the company's stock after purchasing an additional 57,822 shares during theDecember 24, 2024 | marketbeat.comWave Life Sciences announces submission of CTA for WVE-007December 24, 2024 | markets.businessinsider.comWave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in ObesityDecember 23, 2024 | globenewswire.comY Intercept Hong Kong Ltd Cuts Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Y Intercept Hong Kong Ltd decreased its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 57.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,559 shares of the company'sDecember 19, 2024 | marketbeat.comWellington Management Group LLP Has $2.59 Million Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Wellington Management Group LLP trimmed its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 26.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 315,502 shares of the company's stock afterDecember 18, 2024 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of "Buy" from BrokeragesShares of Wave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) have been given an average recommendation of "Buy" by the ten analysts that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, eight have given a buy rating and oDecember 18, 2024 | marketbeat.comWave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare ConferenceDecember 16, 2024 | globenewswire.comPoint72 Asset Management L.P. Cuts Stake in Wave Life Sciences Ltd. (NASDAQ:WVE)Point72 Asset Management L.P. cut its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 75.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 28,096 shares of the company's stock after selDecember 13, 2024 | marketbeat.comBuy Rating for Wave Life Sciences: Favorable Regulatory Environment and Promising WVE-003 DataDecember 12, 2024 | markets.businessinsider.comWave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Fmr LLCFmr LLC lifted its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 174.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,540,190 shares of the company's stock after purchasing an additional 979,110 shares during theDecember 12, 2024 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. grew its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 209.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 844,617 shares of the company's stock aftDecember 12, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Sells 262,075 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)Jacobs Levy Equity Management Inc. reduced its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 71.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 104,526 shares of the company's stockDecember 10, 2024 | marketbeat.comWave Life Sciences: Positioned for Growth with Promising Huntington’s Treatment and Strategic AdvantagesDecember 6, 2024 | markets.businessinsider.comRTW Investments LP Invests $7.38 Million in Wave Life Sciences Ltd. (NASDAQ:WVE)RTW Investments LP bought a new position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 900,000 shares of the company's stock, valued at approxiDecember 5, 2024 | marketbeat.comPolar Asset Management Partners Inc. Takes $3.99 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Polar Asset Management Partners Inc. purchased a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 486,023 shares of the company's stDecember 5, 2024 | marketbeat.com850,000 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Bought by Maven Securities LTDMaven Securities LTD bought a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 850,000 shares of the company's stock, valued at approximately $6,970,000. WaveDecember 4, 2024 | marketbeat.comCinctive Capital Management LP Purchases 256,146 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)Cinctive Capital Management LP grew its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 255.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 356,308 shares of the company's stock after buyDecember 3, 2024 | marketbeat.com344,063 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Bought by Baker BROS. Advisors LPBaker BROS. Advisors LP purchased a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 344,063 shares of the company's stock, valued at approximately $2,821,000. Baker BROS. AdviDecember 2, 2024 | marketbeat.com602,441 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Acquired by Walleye Capital LLCWalleye Capital LLC bought a new position in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 602,441 shares of the company's stock, valued at approximatDecember 2, 2024 | marketbeat.comInsider Selling: Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Sells 50,000 Shares of StockNovember 28, 2024 | insidertrades.comWave Life Sciences Ltd. (NASDAQ:WVE) Receives Consensus Recommendation of "Buy" from BrokeragesWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) has received a consensus rating of "Buy" from the ten research firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and onNovember 23, 2024 | marketbeat.com Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address WVE Media Mentions By Week WVE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WVE News Sentiment▼1.170.60▲Average Medical News Sentiment WVE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WVE Articles This Week▼25▲WVE Articles Average Week Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AXSM News BPMC News TLX News ELAN News LNTH News NUVL News CYTK News VRNA News GRFS News TGTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WVE) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wave Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wave Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
